StonvexLoading…
StonvexStonvexStonvexCore line items from OGE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.19B | $2.92B | $2.61B | $3.30B |
Operating Income | $799.40M | $745.30M | $650.20M | $649.50M |
Net Income | $470.70M | $441.50M | $416.80M | $665.70M |
EPS (Diluted) | $2.32 | $2.19 | $2.07 | $3.32 |
Total Assets | $14.37B | $13.72B | $12.79B | $12.54B |
Total Liabilities | $9.39B | $9.08B | $8.28B | $8.13B |
Cash & Equivalents | $200.00K | $600.00K | $200.00K | $88.10M |
Free Cash Flow OCF − CapEx | $82.70M | $-278.10M | $54.10M | $-98.50M |
Shares Outstanding | 206.10M | 201.00M | 200.30M | 200.20M |